18364 resources
By Version
By Authority
Start Prev Rows 3000 - 3200 Next
Package | Version | Identity | Name/Title | Status | Date | Auth |
---|---|---|---|---|---|---|
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-bromfenac-exclude | Exclude Bromfenac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-bromfenac | Bromfenac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-bumetanide | Bumetanide Medications Value Set | draft | 2022-11 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-calcium-LOINC | LOINC Codes for Serum Calcium | draft | 2018-08 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-celecoxib | Celecoxib Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cloprednol | Cloprednol Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cortisone | Cortisone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cortivazol | Cortivazol Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cyclosporine-exclude | Exclude cyclosporine Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cyclosporine | Cyclosporine Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-deflazacort | Deflazacort Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-desoxycorticosterone | Desoxycorticosterone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-dexamethasone-exclude | Exclude Dexamethasone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-dexamethasone | Dexamethasone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-dexlansoprazole | Dexlansoprazole Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-diclofenac-exclude | Exclude Diclofenac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-diclofenac | Diclofenac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-diflunisal | Diflunisal Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-digoxin-LOINC | LOINC Codes for Digoxin Concentration | draft | 2018-08 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-digoxin | Digoxin Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-eplerenone | Eplerenone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-esomeprazole | Esomeprazole Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ethacrynate | Ethacrynate Medications Value Set | draft | 2022-11 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-etodolac | Etodolac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-fenoprofen | Fenoprofen Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-fludrocortisone | Fludrocortisone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-fluocortolone-exclude | Exclude Fluocortolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-fluocortolone | Fluocortolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-flurbiprofen-exclude | Exclude Flurbiprofen Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-flurbiprofen | Flurbiprofen Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-furosemide | Furosemide Medications Value Set | draft | 2022-11 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-hydrocortisone-exclude | Exclude Hydrocortisone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-hydrocortisone | Hydrocortisone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ibuprofen-exclude | Exclude Ibuprofen Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ibuprofen | Ibuprofen Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-indomethacin | Indomethacin Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ketoprofen-exclude | Exclude Ketoprofen Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ketoprofen | Ketoprofen Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ketorolac-exclude | Exclude Ketorolac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ketorolac | Ketorolac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-lansoprazole | Lansoprazole Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-magnesium-LOINC | LOINC Codes for Serum Potassium | draft | 2018-08 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-mefenamate | Mefenamate Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-meloxicam | Meloxicam Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-meprednisone | Meprednisone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-methylprednisolone-exclude | Exclude Methylprednisolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-methylprednisolone | Methylprednisolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-misoprostol | Misoprostol Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-nabumetone | Nabumetone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-naproxen | Naproxen Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-nepafenac-exclude | Exclude Nepafenac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-nepafenac | Nepafenac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-omeprazole | Omeprazole Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-oxaprozin | Oxaprozin Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-pantoprazole | Pantoprazole Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-paramethasone | Paramethasone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-piroxicam-exclude | Exclude Piroxicam Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-piroxicam | Piroxicam Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-potassium-LOINC | LOINC Codes for Serum Potassium | draft | 2018-08 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-prednisolone-exclude | Exclude Prednisolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-prednisolone | Prednisolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-prednisone | Prednisone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-prednylidene | Prednylidene Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-rabeprazole | Rabeprazole Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-renal-LOINC | LOINC Codes for Renal Function | draft | 2018-08 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-rimexolone-exclude | Exclude Rimexolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-rimexolone | Rimexolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-spironolactone | Spironolactone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-sulindac | Sulindac Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-tolmetin | Tolmetin Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-topicaldiclofenac | Topical Diclofenac Medications Value Set | draft | 2022-11 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-torsemide | Torsemide Medications Value Set | draft | 2022-11 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-triamcinolone-exclude | Exclude Triamcinolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-triamcinolone | Triamcinolone Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-trilostane | Trilostane Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-warfarin | Warfarin Medications Value Set | draft | 2018-07 | hl7 |
hl7.fhir.uv.pddi | R4 | CodeSystem/codesystem-PDDICDS-indicator | PDDI CDS indicator | draft | 2024-02 | hl7 |
ihe.pharm.meow | R5 | ImplementationGuide/ihe.pharm.meow | IHE Pharmacy Medication Overview | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/DosagingInformation | Dosaging (model) | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/IHEMedication | Medicinal product | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/MedicationOverview | Medication Overview Bundle | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/MedicationOverviewComposition | Medication Overview Composition | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/MedicationOverviewLM | Medication Overview (model) | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/MedicationTreatment | Medication Treatment | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/MedicationTreatmentLM | Medication Treatment (model) | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/MedicationTreatmentLine | Medication Treatment Line | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/MedicationTreatmentLineLM | Medication Treatment Line (model) | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/MedicinalProductLM | Medicinal product (model) | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/PatientLM | Patient (model) | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/PractitionerLM | Practitioner (model) | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/ihe-ext-medication-classification | Medication - Classification | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/ihe-ext-medication-device | Medication - Device | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/ihe-ext-medication-productname | Medication - Product Name | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/ihe-ext-medication-sizeofitem | Medication - Size of Item | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/ihe-ext-medicationstatement-substitution | MedicationStatement - Substitution | active | 2024-06 | ihe |
ihe.pharm.meow | R5 | StructureDefinition/ihe-ext-medicationstatement-verificationinformation | MedicationStatement - Verification Information | active | 2024-06 | ihe |
ihe.pcc.aps | R4 | ImplementationGuide/ihe.pcc.aps | Antepartum Summary | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.AdvanceDirectivesObservation | Advance Directives Observation | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.AlcoholUseFrequency | alcohol Use | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.BodyWeightMeasuredPrePregnancy | Body Weight Measured Pre Pregnancy | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.DateOfFirstPrenatalVisit | Date Of First Prenatal Visit | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.DateOfLastLiveBirth | Date Of Last Live Birth | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.DateOfLastMenstralPeriod | Date Of Last Menstral Period | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.DateOfLastOtherPregnancyOutcome | Date Of Last Other Pregnancy Outcome | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.DeliveryDateClinicalEstimate | Delivery Date Clinical Estimate | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.DeliveryDateEstimatedFromLMP | Delivery Date Clinical Estimated From Last Menstral Period | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.DeliveryDateEstimatedFromOvulationDate | Delivery Date Clinical Estimated From Ovulation Date | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.DeliveryRisk | Delivery Risk | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.Diet | Diet | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.DurationOfMenstrualFlow | Duration of Menstrual Flow | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.Exercise | Exercise | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.FetusGestationalAge | Fetus Gestational Age | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.FetusGestationalAgeClinicalEstimate | Fetus Gestational Age Clinical Estimate | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.FetusGestationalAgeEstimatedFromLMP | Fetus Gestational Age Estimated From LMP | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.FetusGestationalAgeEstimatedFromOvulationDate | Fetus Gestational Age Estimated From Ovulation Date | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.FrequencyOfMenstrualCycles | Frequency of Menstrual Cycles | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.GestationalAge | Gestational Age | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.Homelessness | Homelessness | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.LaborRisk | Labor Risk | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.Menarche | Menarche | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.MensesMonthly | Menses Monthly | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.MenstrualStatus | Menstrual Status | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.MultiplePregnancy | Multiple Pregnancy | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfAbortions | Number of Abortions | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfAbortionsInduced | Number of Abortions Induced | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfAbortionsSpontanious | Number of Abortions Spontanious | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfBirthsStillLiving | Births Still Living | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfBirthsToTerm | Births to Term | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfEctopicPregnancies | Number of Ectopic Pregnancy | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfLiveBirths | Number of Live Births | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfOtherPregnancyOutcomes | Number Of Other Pregnancy Outcomes | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfPregnancies | Number of Pregnancies | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfPrenatalVisitsForThisPregnancy | Number Of Prenatal Visits For This Pregnancy | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfPretermBirths | Number of Preterm Births | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfPreviousCesareanDeliveries | Number Of Previous Cesarean Deliveries | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfPreviousLiveBirthsNowDead | Number Of Previous Live Births Now Dead | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfStillbornBirths | Number of Stillborn Births | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.NumberOfTotalBirths | Number of Total Births | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.PCC.APS.Composition | Antapartum Summary | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.PregnancyEducationObservation | Pregnancy Education Observation | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.PregnancyHistory | Pregnancy History Observations | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.PriorMensesDate | Prior Menses Date | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.SmokingTobaccoUseFrequency | Smoking and Tobacco Use Frequency | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.ToxicExposure | Toxic Exposure | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.ViolenceRisk | At risk of domestic violence | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.drugUse | Drug Use | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.hCGPlus | hCG+ | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | StructureDefinition/IHE.ODH.EmploymentStatus.StructuredDefinition | Employment Status | draft | 2020-01 | ihe |
ihe.pcc.aps | R4 | ValueSet/Advance.Directives.VS | Advance Directives | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | ValueSet/Alcohol.USe.Frequency.VS | Alcohol USe Frequency | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | ValueSet/Antepartum.Education.VS | Antepartum Education | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | ValueSet/Antepartum.Family.History.and.Genetic.Screening.VS | Antepartum Family History and Genetic Screening | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | ValueSet/Antepartum.History.of.Infection.VS | Antepartum History of Infection | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | ValueSet/Antepartum.History.of.Past.Illness.VS | Antepartum History of Past Illness | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | ValueSet/Antepartum.Laboratory.VS | Antepartum Laboratory | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | ValueSet/Antepartum.Review.of.Systems.Menstrual.History.VS | Antepartum Review of Systems Menstrual History | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | ValueSet/Smoking.Status.VS | Smoking Status | draft | 2023-10 | ihe |
ihe.pcc.aps | R4 | ValueSet/Smoking.Tabbacco.Use.Frequency.VS | Smoking Tabbacco Use Frequency | draft | 2023-10 | ihe |
hl7.fhir.uv.phr | R4 | ImplementationGuide/hl7.fhir.uv.phr | Personal Health Records | draft | 2025-02 | hl7 |
who.fhir.anc-cds | R4 | Questionnaire/ANCA | ANC.A. Registration | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCB10 | ANC.B10 Counselling & treatment | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCB11 | ANC.B11 Referral needed? | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCB12 | ANC.B12 Scheduling | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCB4 | ANC.B4 Confirm pregnancy | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCB5 | ANC.B5 Quick check | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCB6 | ANC.B6 Profile | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCB7 | ANC.B7 Symptoms & Follow-up | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCB8 | ANC.B8 Physical exam | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCB9 | ANC.B9 Lab tests & imaging | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCC | ANC.C. Referral | active | 2025-01 | who |
who.fhir.anc-cds | R4 | Questionnaire/ANCEnd | ANC.End End | active | 2025-01 | who |
who.fhir.anc-cds | R4 | ImplementationGuide/who.fhir.anc-cds | WHO Antenatal Care Guideline Implementation Guide | draft | 2017-02 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-a-de13 | Co-habitants | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-allergyintolerance | ANC AllergyIntolerance | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-appointment | ANC Appointment | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de1 | Counselling conducted on caffeine reduction | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de10 | Reason counselling on second-hand smoke was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de104 | Vitamin A supplementation not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de107 | Amount of daily calcium supplements provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de108 | Reason calcium not prescribed | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de113 | Risk of pre-eclampsia | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de114 | Pre-eclampsia risk counselling provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de115 | Amount of daily aspirin prescribed until delivery | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de116 | Reason aspirin not prescribed | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de121 | Risk of gestational diabetes mellitus (GDM) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de124 | Gestational diabetes mellitus (GDM) risk counselling conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de125 | Counselling conducted on HIV risk | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de126 | PrEP for HIV prevention provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de127 | Reason PrEP for HIV prevention was not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de13 | Counselling conducted on condom use | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de132 | Amount of oral PrEP provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de133 | Counselling conducted on seeking care when danger signs occur | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de134 | Counsel to immediately go to the hospital if severe danger signs are present | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de135 | Counselling on ANC contact schedule conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de136 | Counselling conducted on birth preparedness and complications readiness | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de137 | Planned birth place | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de14 | Reason counselling on condom use was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de142 | Counselling conducted on Rh factor negative | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de143 | Counselling conducted on intrapartum antibiotic to prevent early neonatal Group B Streptococcus (GBS) infection | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de144 | Counselling on postpartum family planning conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de145 | Family planning method selected | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de164 | Counselling conducted on breastfeeding | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de17 | Counselling conducted on alcohol / substance use | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de175 | Reason tetanus toxoid (TT) vaccination not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de18 | Reason counselling on alcohol / substance use was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de181 | Counselling conducted on Hep B negative | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de188 | No doses of hepatitis B | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de189 | Reason Hep B vaccination not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de197 | Reason flu vaccine not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de2 | Reason counselling on caffeine reduction was not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de203 | IPV first-line support provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de204 | Reason IPV first line support not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de21 | Counselling conducted on non-pharma measures to relieve nausea and vomiting | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de210 | What additional type of care provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de216 | Safety assessement | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de217 | Has the physical violence happened more often or gotten worse over the past 6 months | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de218 | Has he ever used a weapon or threatened you with a weapon | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de219 | Has he ever tried to strangle you | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de22 | Reason counselling on non-pharma measures to relieve nausea and vomiting was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de220 | Has he ever beaten you when you were pregnant | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de221 | Is he violently and constantly jealous of you | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de222 | Do you believe he could kill you | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de223 | Referrals made as part of first-line support and care | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de224 | Was client referred | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de233 | Preventive antihelminthic treatment provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de237 | Reason no preventative treatment provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de241 | Counselling conducted on malaria prevention | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de242 | Reason counselling on malaria prevention was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de25 | Counselling conducted on pharmacological treatments for nausea and vomiting | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de251 | Reason malaria prophylaxis not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de256 | Referred to hospital | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de257 | Reason referral not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de26 | Reason counselling on pharmacological treatments for nausea and vomiting was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de29 | Counselling conducted on diet and lifestyle changes to prevent and relieve heartburn | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de30 | Reason counselling on diet and lifestyle changes to prevent and relieve heartburn was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de33 | Counselling conducted on antacid preparations to relieve heartburn | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de34 | Reason counselling on antacid preparations to relieve heartburn was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de37 | Counselling on non-pharmacological treatment for the relief of leg cramps | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de38 | Reason counselling on non-pharmacological treatment for the relief of leg cramps was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de41 | Counselling conducted on use of magnesium and calcium to relieve leg cramps | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de42 | Reason counselling on use of magnesium and calcium to relieve leg cramps was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de45 | Counselling conducted on dietary modifications to relieve constipation | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de46 | Reason counselling on dietary modifications to relieve constipation was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de49 | Counselling conducted on use of wheat bran or other fibre supplements to relieve constipation | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de5 | Counselling conducted on tobacco cessation | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de50 | Reason counselling on use of wheat bran or other fibre supplements to relieve constipation was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de53 | Counselling conducted on regular exercise, physiotherapy, support belts and acupuncture to relieve low back and pelvic pain | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de54 | Reason counselling on regular exercise, physiotherapy, support belts and acupuncture to relieve low back and pelvic pain was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de57 | Counselling conducted on non-pharmacological options for varicose veins and oedema | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de58 | Reason counselling on non-pharmacological options for varicose veins and oedema was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de6 | Reason counselling on tobacco cessation was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de61 | Counselling conducted on healthy eating and keeping physically active | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de62 | Reason counselling on healthy eating and keeping physically active was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de65 | Counselling conducted on increasing daily energy and protein intake | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de66 | Reason counselling on increasing daily energy and protein intake was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de69 | Counselling conducted on balanced energy and protein dietary supplementation | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de70 | Reason counselling on balanced energy and protein dietary supplementation was not conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de73 | Hypertension | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de74 | Severe hypertension | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de75 | Pre-eclampsia | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de76 | Severe pre-eclampsia | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de77 | Counselling conducted on hypertension | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de78 | Counselling conducted on HIV positive | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de79 | Counselling conducted on hepatitis B positive | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de80 | Counselling conducted on hepatitis C positive | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de81 | Syphilis counselling and treatment | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de82 | Syphilis counselling, treatment and further testing | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de83 | Seven-day antibiotic regimen for asymptomatic bacteriuria (ASB) provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de84 | Reason seven-day antibiotic regimen for asymptomatic bacteriuria (ASB) not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de87 | Counselling conducted on TB screening positive | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de88 | Counselling conducted on gestational diabetes mellitus (GDM) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de89 | Counselling conducted on diabetes mellitus (DM) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de9 | Counselling conducted on second-hand smoke | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de90 | Counselling conducted on anaemia | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de95 | Amount of daily dose of folic acid prescribed | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b10-de96 | Reason iron and folic acid not prescribed | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b4-de1 | Pregnancy confirmed | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b5-de48 | Danger signs | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b5-de5 | Specific health concern(s) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de100 | Tetanus toxoid-containing vaccine (TTCV) immunization history | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de105 | Flu immunization history | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de109 | Current medications | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de139 | Daily caffeine intake | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de14 | Last menstrual period (LMP) date | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de145 | Clinical enquiry for alcohol and other substance use done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de146 | Current alcohol and/or other substance use | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de15 | Ultrasound done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de153 | Tobacco use | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de154 | Recently quit tobacco products | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de155 | Exposure to second-hand smoke | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de156 | Partner HIV status (reported) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de160 | Contraceptive use of male condoms | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de161 | Contraceptive use of female condoms | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de17 | Gestational age | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de18 | Source of gestational age | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de22 | Expected date of delivery (EDD) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de24 | Number of pregnancies (gravida) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de25 | Number of miscarriages and/or abortions | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de26 | Number of live births | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de27 | Whether last live birth was preterm | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de31 | Number of stillbirths | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de32 | Parity | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de33 | Number of caesarian sections | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de34 | Past pregnancy complications | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de51 | Substance use during past pregnancy specification | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de57 | Allergies | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de72 | Past surgeries | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de83 | Existing chronic health conditions | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b6-de99 | HIV diagnosis date | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b7-de1 | Medication follow-up | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b7-de18 | Persistent physiological symptoms | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b7-de43 | Current physiological symptoms | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b7-de71 | Presenting signs and symptoms that trigger suspicion of IPV and clinical inquiry | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b7-de97 | Woman discloses or is suspected to be subjected to intimate partner violence | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b7-de98 | Fetal movement | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b7-ded9 | Persistent behaviours | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de1 | Height | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de10 | Expected weight gain | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de100 | Oedema severity | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de105 | Symphysis-fundal height (SFH) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de106 | Fetal heartbeat present | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de107 | Fetal heart rate | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de108 | Second fetal heart rate | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de109 | Number of fetuses | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de110 | Number of fetuses unknown | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de111 | Fetal presentation | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de117 | Presenting signs/conditions for IPV | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de121 | Clinical enquiry for IPV | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de122 | Reason clinical enquiry not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de128 | Has the woman been subjected to intimate partner violence | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de129 | Types of IPV | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de15 | Average weight gain per week | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de16 | Total weight gain (kg) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de17 | Systolic blood pressure | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de19 | Diastolic blood pressure | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de2 | Pre-gestational weight | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de20 | Repeat systolic blood pressure | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de21 | Repeat diastolic blood pressure | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de22 | Blood pressure cannot be taken | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de23 | Reason blood pressure cannot be taken | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de27 | Symptoms of severe pre-eclampsia | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de3 | Current weight | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de34 | Body temperature | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de35 | Second body temperature | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de36 | Pulse rate | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de37 | Second pulse rate | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de38 | Pallor present | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de39 | Respiratory exam result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de4 | BMI | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de49 | Oximetry | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de5 | Weight category | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de50 | Cardiac exam result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de61 | Breast exam result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de71 | Abdominal exam result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de79 | Pelvic exam result (visual) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de92 | Cervical exam conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de93 | Cervical dilation | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de94 | Oedema present | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b8-de95 | Oedema type | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de1 | Ultrasound required | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de102 | Reason syphilis test not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de107 | Syphilis test result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de110 | Syphilis diagnosis | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de113 | Urine test required | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de115 | Urine test ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de116 | Urine test type | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de120 | Reason urine test not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de124 | Midstream urine culture (recommended) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de129 | Midstream urine Gram-staining | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de13 | Placenta location | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de132 | Urine dipstick result - nitrites | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de138 | Urine dipstick result - leukocytes | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de144 | Urine dipstick result - protein | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de150 | Urine dipstick result - glucose | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de156 | Asymptomatic bacteriuria (ASB) diagnosis | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de160 | Blood glucose test ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de162 | Blood glucose test type | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de163 | Fasting plasma glucose | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de164 | 75 g oral glucose tolerance test (OGTT) - fasting glucose | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de165 | 75 g oral glucose tolerance test (OGTT) - 1 hour | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de166 | 75 g oral glucose tolerance test (OGTT) - 2 hours | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de167 | Random plasma glucose | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de168 | Blood glucose test result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de169 | Gestational diabetes mellitus (GDM) diagnosis | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de172 | Diabetes mellitus (DM) during pregnancy diagnosis | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de176 | Blood haemoglobin test ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de177 | Blood haemoglobin test type | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de181 | Reason blood haemoglobin test not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de186 | Blood haemoglobin test result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de187 | Anaemia diagnosis | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de190 | Hematocrit (Ht) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de191 | White blood cell (WBC) count | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de192 | Platelet count | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de193 | TB screening recommended | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de195 | TB screening ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de196 | Reason TB screening not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de2 | Ultrasound scan ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de206 | TB screening result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de21 | Blood type test ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de214 | Other test(s) result(s) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de24 | Blood type | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de29 | Rh factor | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de33 | HIV test required | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de34 | HIV test ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de36 | Reason HIV test not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de41 | HIV test result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de45 | HIV status | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de48 | Partner HIV test result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de49 | Partner HIV test ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de5 | Reason ultrasound scan not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de55 | Partner HIV status (confirmed) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de58 | High risk for HIV | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de59 | Hepatitis B test required | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de61 | Hepatitis B test ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de62 | Hepatitis B test type | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de66 | Hepatitis B test result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de74 | Hepatitis B diagnosis | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de77 | Hepatitis C test required | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de79 | Hepatitis C test ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de80 | Hepatitis C test type | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de84 | Reason Hepatitis C test not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de89 | Hepatitis C test result | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de9 | Amniotic fluid level | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de92 | Hepatitis C diagnosis | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de97 | Syphilis test ordered | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-b9-de98 | Syphilis test type | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-base-encounter | ANC Base Encounter | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-base-patient | ANC Base Patient | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-c-de2 | Reason for referral | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-c-de5 | Any treatment given before referral | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-careplan | ANC CarePlan | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-careteam | ANC CareTeam | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-condition | ANC Condition | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-encounter | ANC Encounter | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-1 | Reason for closing ANC record | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-12 | Delivery date | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-13 | Place of delivery | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-17 | Preterm Birth | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-18 | Delivery mode | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-23 | Birth weight | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-24 | Exclusively breastfeeding | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-25 | Delivery complications | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-38 | Date of miscarriage or abortion | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-39 | Date of death | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-end-40 | Cause of death | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-episodeofcare | ANC EpisodeOfCare | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-group | ANC Group | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-immunization | ANC Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-immunizationnotdone | ANC Immunization Not Done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-location | ANC Location | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-measurereport | ANC MeasureReport | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-medicationnotrequested | ANC Medication Not Requested | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-medicationrequest | ANC MedicationRequest | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-observation | ANC Observation | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-observationnotdone | ANC Observation Not Done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-organization | ANC Organization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-patient | ANC Patient | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-practitioner | ANC Practitioner | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-practitionerrole | ANC PractitionerRole | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-procedure | ANC Procedure | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-procedurenotdone | ANC Procedure Not Done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-relatedperson | ANC RelatedPerson | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-servicenotrequested | ANC Service Not Requested | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/anc-servicerequest | ANC ServiceRequest | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/blood-glucose-test | Blood Glucose Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/blood-haemoglobin-test | Blood Haemoglobin Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/blood-type-test | Blood Type Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/contactnumber | ANC contact number | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/educationlevel | Highest level of education achieved | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/flu-immunization | Flu Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/hepatitis-b-1-immunization | Hepatitis B-1 Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/hepatitis-b-2-immunization | Hepatitis B-2 Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/hepatitis-b-3-immunization | Hepatitis B-3 Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/hepatitis-b-test | Hepatitis B Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/hepatitis-c-test | Hepatitis C Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/hiv-test | HIV Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/iron-supplement | Iron Supplement | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/malaria-prophylaxis-iptp-sp-dose-1 | Malaria Prophylaxis (IPTp-SP) Dose 1 | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/malaria-prophylaxis-iptp-sp-dose-2 | Malaria Prophylaxis (IPTp-SP) Dose 2 | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/malaria-prophylaxis-iptp-sp-dose-3 | Malaria Prophylaxis (IPTp-SP) Dose 3 | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/occupation | Occupation | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/other-test | Other Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/partner-hiv-test | Partner HIV Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/referral-provider | Referral Provider | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/referral | Referral | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/reminder | Woman wants to receive reminders during pregnancy | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/syphilis-test | Syphilis Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/tb-screening | TB Screening | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/tetanus-toxoid-tt-1-immunization | Tetanus toxoid (TT) 1 Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/tetanus-toxoid-tt-2-immunization | Tetanus toxoid (TT) 2 Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/tetanus-toxoid-tt-3-immunization | Tetanus toxoid (TT) 3 Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/tetanus-toxoid-tt-4-immunization | Tetanus toxoid (TT) 4 Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/tetanus-toxoid-tt-5-immunization | Tetanus toxoid (TT) 5 Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/ultrasound | Ultrasound | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/urine-test | Urine Test | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | StructureDefinition/vitamin-a-supplement | Vitamin A Supplement | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-allergyintolerance | WHO AllergyIntolerance | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-appointment | WHO Appointment | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-careplan | WHO CarePlan | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-careteam | WHO CareTeam | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-condition | WHO Condition | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-doNotPerformReason | WHODoNotPerformReason | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-encounter | WHO Encounter | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-episodeofcare | WHO EpisodeOfCare | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-group | WHO Group | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-groupdefinition | WHO Group Definition | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-immunization | WHO Immunization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-immunizationnotdone | WHO Immunization Not Done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-location | WHO Location | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-measurereport | WHO MeasureReport | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-medicationnotrequested | WHO Medication Not Requested | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-medicationrequest | WHO MedicationRequest | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-notDone | WHO NotDone Extension | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-notDoneReason | WHO NotDoneReason Extension | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-observation | WHO Observation | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-observationnotdone | WHO Observation Not Done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-organization | WHO Organization | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-patient | WHO Patient | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-practitioner | WHO Practitioner | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-practitionerrole | WHO PractitionerRole | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-procedure | WHO Procedure | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-procedurenotdone | WHO Procedure Not Done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-relatedperson | WHO RelatedPerson | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-reportedLocation | WHO Reported Location | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-servicenotrequested | WHO Service Not Requested | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | http://fhir.org/guides/who/core/StructureDefinition/who-servicerequest | WHO ServiceRequest | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND01 | ANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimester | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND02 | ANC.IND.02 Percentage of pregnant women who received iron and folic acid (IFA) supplements for 90+ days | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND03 | ANC.IND.03 Percentage of pregnant women screened for syphilis during ANC | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND04 | ANC.IND.04 Percentage of pregnant women with at least four ANC contacts | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND05 | ANC.IND.05 Percentage of pregnant women with a minimum of eight antenatal care contacts | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND06 | ANC.IND.06 Pregnant women who received counselling on danger signs (%) during at least one ANC contact | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND07 | ANC.IND.07 Percentage of pregnant women with at least one blood pressure measure during ANC | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND08 | ANC.IND.08 Percentage of pregnant women with at least one blood pressure measure in the third trimester during ANC | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND09 | ANC.IND.09 Percentage of pregnant women whose baby’s heartbeat was listened to at least once during ANC | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND10 | ANC.IND.10 Percentage of pregnant women with an ultrasound scan before 24 weeks | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND11 | ANC.IND.11 Percentage of women who received three doses or more of intermittent preventive therapy for malaria (IPTp) during their last pregnancy | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND12 | ANC.IND.12 Percentage of pregnant women counselled and tested for HIV | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | Measure/ANCIND13 | ANC.IND.13 Percentage of pregnant women who received oral pre-exposure prophylaxis (PrEP) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ConceptMap/ICD-10 | ICD-10 | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ConceptMap/ICD-11 | ICD-11 | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ConceptMap/ICF | ICF | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ConceptMap/ICHI | ICHI | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ConceptMap/LOINC | LOINC | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ConceptMap/SNOMED-CT | SNOMED-CT | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | OperationDefinition/Measure-evaluate-measure | Evaluate Measure | draft | 2019-11 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-a-de13 | Co-habitants | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-a-de14 | Co-habitants Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-activity-codes | ANC Activity Codes | active | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de1 | Counselling on Caffeine Reduction | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de10 | Counselling on Second-Hand Smoke | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de102 | Type of vitamin A supplement dosage provided Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de104 | Vitamin A supplementation not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de105 | Vitamin A supplementation not provided Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de108 | Reason calcium not prescribed | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de109 | Reason calcium not prescribed Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de113 | Risk of pre-eclampsia | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de114 | Pre-eclampsia risk counselling provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de116 | Reason aspirin not prescribed | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de117 | Reason aspirin not prescribed Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de121 | Risk of gestational diabetes mellitus (GDM) | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de124 | Gestational diabetes mellitus (GDM) risk counselling conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de125 | Counselling conducted on HIV risk | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de126 | PrEP for HIV prevention provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de127 | Reason PrEP for HIV prevention was not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de128 | Reason PrEP for HIV prevention was not provided Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de13 | Counselling on Condom Use | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de133 | Counselling conducted on seeking care when danger signs occur | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de134 | Counsel to immediately go to the hospital if severe danger signs are present | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de135 | Counselling on ANC contact schedule conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de136 | Counselling conducted on birth preparedness and complications readiness | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de137-choices-grouper | Planned birth place Choices Grouper | draft | 2021-09 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de137 | Planned birth place | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de138 | Planned birth place Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de14 | Counselling on Condom Use | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de140 | Planned birth place - Home Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de142 | Counselling conducted on Rh factor negative | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de143 | Counselling conducted on intrapartum antibiotic to prevent early neonatal Group B Streptococcus (GBS) infection | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de144 | Counselling on postpartum family planning conducted | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de145-choices-grouper | Family planning method selected Choices Grouper | draft | 2021-09 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de145 | Family planning method selected | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de146 | Family planning method selected - Copper-bearing intrauterine device (Cu-IUD) Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de147 | Family planning method selected - Levonorgestrel intrauterine device (LNG-IUD) Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de148 | Family planning method selected Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de162 | Family planning method selected - Female sterilization Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de164 | Counselling conducted on breastfeeding | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de165 | Tetanus toxoid (TT) 1 immunization provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de167 | Tetanus toxoid (TT) 2 immunization provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de169 | Tetanus toxoid (TT) 3 immunization provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de17 | Counselling on Alcohol Substance Abuse | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de171 | Tetanus toxoid (TT) 4 immunization provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de173 | Tetanus toxoid (TT) 5 immunization provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de175 | Reason tetanus toxoid (TT) vaccination not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de176 | Reason tetanus toxoid (TT) vaccination not provided Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de18 | Counselling on Alcohol Substance Abuse | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de181 | Counselling conducted on Hep B negative | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de182 | Hepatitis B-1 immunization provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de184 | Hepatitis B-2 immunization provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de186 | Hepatitis B-3 immunization provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de188 | No doses of hepatitis B | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de189 | Reason Hep B vaccination not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de190 | Reason Hep B vaccination not provided Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de195 | Flu immunization provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de197 | Reason flu vaccine not provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de198 | Reason flu vaccine not provided Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de2 | Counselling on Caffeine Reduction | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de203 | IPV first-line support provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de204 | Reason IPV first line support not done | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de205 | Reason IPV first line support not done Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de21 | Counselling on Non-Pharma Measures to Relieve Nausea and Vomiting | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de210 | What additional type of care provided | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de211 | What additional type of care provided Choices | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de216 | Safety assessement | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de217 | Has the physical violence happened more often or gotten worse over the past 6 months | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de218 | Has he ever used a weapon or threatened you with a weapon | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de219 | Has he ever tried to strangle you | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de22 | Counselling on Non-Pharma Measures to Relieve Nausea and Vomiting | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de220 | Has he ever beaten you when you were pregnant | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de221 | Is he violently and constantly jealous of you | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de222 | Do you believe he could kill you | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de223 | Referrals made as part of first-line support and care | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de224 | Was client referred | draft | 2025-01 | who |
who.fhir.anc-cds | R4 | ValueSet/anc-b10-de225 |